Why JOYY Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket

Shares of JOYY Inc (NASDAQ:JOYY) rose sharply in pre-market trading after the company reported financial results for the second quarter.

JOYY reported quarterly earnings of $1.24 per share which missed the analyst consensus estimate of $1.28 per share. The company reported quarterly sales of $590.754 million which beat the analyst consensus estimate of $574.118 million.

JOYY said it sees third-quarter sales of $602.000 million-$622.000 million, versus market estimates of $591.756 million.

JOYY shares jumped 3.6% to $77.70 in pre-market trading.

Here are some other stocks moving in pre-market trading.

Gainers

• Reading International Inc (NASDAQ:RDIB) gained 98.4% to $18.85 in pre-market trading after jumping around 9% on Tuesday.
• YY Group Holding Ltd (NASDAQ:YYGH) rose 74% to $2.00 in pre-market trading after the company announced the cancellation of a $5.94 million second financing tranche and all outstanding warrants.
• CID HoldCo Inc (NASDAQ:DAIC) rose 44.9% to $5.62 in pre-market trading after surging 124% on Tuesday.
• Lucas GC Ltd (NASDAQ:LGCL) rose 32.1% to $0.058 in pre-market trading after dipping over 6% on Tuesday.
• Founder Group Ltd (NASDAQ:FGL) gained 29.2% to $0.27 in pre-market trading. On Tuesday, Founder Group announced that it has completed the acquisition of a 19.90% equity interest in Nichcom Go Sdn. Bhd.
• Trugolf Holdings Inc (NASDAQ:TRUG) gained 27.8% to $0.75 in pre-market trading after declining 10% on Tuesday. TruGolf recently announced it will acquire tokenization technology company Polymath Research For ~19.9% Of TRUG Class A Shares Outstanding.
• Expion360 Inc (NASDAQ:XPON) rose 25% to $6.59 in pre-market trading after dropping 15% on Tuesday. Expion360 recently announced a $3.425 million acquisition of Eastern Louisiana Oil ans Gas Exploration Prospect.
• Biohaven Ltd (NYSE:BHVN) rose 9.6% to $15.76 in pre-market trading. Biohaven and SK Biopharmaceuticals entered into a strategic global licensing agreement for novel Kv7 ion channel platform and opakalim, lead candidate for epilepsy.
• Anbio Biotechnology (NASDAQ:NNNN) shares gained 7.4% to $8.41 in pre-market trading.

Losers

• Greenland Mines Ltd (NASDAQ:GRML) tumbled 29% to $6.90 in pre-market trading after announcing a proposed public offering.
• Netcapital Inc (NASDAQ:NCPL) fell 24.8% to $0.44 in pre-market trading after jumping over 126% on Tuesday.
• Xiao-I Corp (NASDAQ:AIXI) fell 16.8% to $1.09 in pre-market trading after jumping 186% on Tuesday. Xiao-I recently announced it will change its ADS ratio from 1‑to‑60 to 1‑to‑420 ordinary shares and disclosed it received a non‑compliance notice from Nasdaq.
• Akanda Corp (NASDAQ:AKAN) declined 15% to $4.21 in pre-market trading after jumping 34% on Tuesday.
• Advasa Holdings (NASDAQ:ADBT) fell 14.1% to $5.38 in pre-market trading after dipping around 48% on Tuesday. Advasa Holdings, on Tuesday, completed a direct listing on Nasdaq under the ticker symbol “ADBT”.
• Biodexa Pharmaceuticals PLC-ADR (NASDAQ:BDRX) fell 13.6% to $1.02 in pre-market trading.
• 707 Cayman Holdings Ltd (NASDAQ:JEM) fell 12.4% to $5.95 in pre-market trading. 707 Cayman Holdings shares jumped 78% on Tuesday after the company announced signing of a term sheet to acquire Crucial Innovation, supported by $10.25 million financing led by GeoNova Holdings.
• Spyre Therapeutics Inc (NASDAQ:SYRE) fell 12.3% to $94.16 in pre-market trading after the company announced topline results from the RA sub-study of its Phase 2 SKYWAY basket trial evaluating SPY072 in rheumatic diseases. The results did not meet the company’s internal bar to prioritize advancement of SPY072 in RA.
• Intuit Inc (NASDAQ:INTU) fell 11.7% to $315.50 in pre-market trading after the company reported upbeat fourth-quarter financial results but issued FY27 guidance below estimates.
• Zoom Communications Inc (NASDAQ:ZM) fell 5.8% to $95.10 in pre-market trading as the company reported better-than-expected financial results for the second quarter but issued soft guidance for the third quarter.

Photo via Shutterstock